Parkirop 0.25mg Tablet
By Parkirop
Rx
10 Tablet in a Strip

Composition
Ropinirole(0.25mg)

Manufacturer - Cadila Pharmaceuticals Ltd
Sarkhej-Dholka Road, Bhat, Ahmedabad-382 210, INDIA.

Expires on or after
October, 2025

liver
When using Parkirop 0.25mg Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment while taking this medication. It is highly advised to consult your doctor before starting treatment. Please note that the use of Parkirop 0.25mg Tablet is not recommended for individuals with severe liver disease. If you have any liver concerns, make sure to seek guidance from your healthcare provider to ensure your safety and well-being.

kidney
Parkirop 0.25mg Tablet requires caution in severe kidney disease. Dose adjustment may be necessary. Consult your doctor.

alcohol
Caution is advised when drinking alcohol while taking Parkirop 0.25mg Tablet. It is important to consult your doctor beforehand.

driving
When taking Parkirop 0.25mg Tablet, be cautious while driving. It may reduce alertness, impact vision, or cause drowsiness and dizziness, which can affect your ability to drive safely. Avoid driving if experiencing these symptoms.

pregnancy
Parkirop 0.25mg Tablet may not be safe to use during pregnancy. There are limited human studies, but animal studies have shown possible harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor.

breastfeeding
Parkirop 0.25mg Tablet is likely unsafe while breastfeeding. Limited data indicates it may pass into breastmilk and harm the baby. This medication suppresses serum prolactin and could affect breastfeeding.
Habit Forming | No |
Chemical Class | Indolines Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Dopamine agonists |
₹14.28
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024